pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
alintegimod
alintegimod [INN]
Colorectal Cancer
7 Hills Pharma LLC
0 catalysts
Phase 2
alisertib
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Aurora kinase A
$PBYIPUMA BIOTECHNOLOGY, INC.
0 catalysts
Phase 2
alnodesertib
alnodesertib [INN]
Metastatic Colorectal Cancer
Artios Pharma Ltd
0 catalysts
← prev
page 32 of 53
next →
131
Pain89
Neurology1
Phase 2
alogabat
Autism Spectrum Disorder (ASD)
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
alpha-1 proteinase inhibitor (human)
Prolastin (alpha-1 proteinase inhibitor (human))
Lung Transplant Rejection
Neutrophil elastase
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 2
alpha-1 proteinase inhibitor (human) second generation
alpha-1 proteinase inhibitor (human)
Alpha-1 Antitrypsin Deficiency (A1AD)
Neutrophil elastase
$KMDAKAMADA LTD
0 catalysts
Phase 2
alrizomadlin
alrizomadlin [INN]
Lung Adenocarcinoma
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 2
alvelestat
alvelestat [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$MREOMereo BioPharma Group plc
0 catalysts
Phase 2
amantadine hydrochloride
Amantadine Hydrochloride (amantadine hydrochloride)
Traumatic Brain Injury
Matrix protein 2Glutamate [NMDA] receptor
Shinkei Therapeutics LLC
0 catalysts
Phase 2
ametefgene parvec
ametefgene parvec [INN]
Parkinson's Disease
Asklepios BioPharmaceutical Inc
0 catalysts
Phase 2
amezalpat
amezalpat [INN]
Metastatic Hepatocellular Carcinoma (HCC)
$TPSTTempest Therapeutics, Inc.
0 catalysts
Phase 2
amezosvatein
amezosvatein [INN]
Herpes Zoster (Shingles)
Curevo Inc
0 catalysts
Phase 2
amiselimod hydrochloride
Ulcerative Colitis
Sphingosine 1-phosphate receptor
Salix Pharmaceuticals Ltd
0 catalysts
Phase 2
amitriptyline hydrochloride
Amitriptyline Hydrochloride (amitriptyline hydrochloride)
Chemotherapy Induced Peripheral Neuropathy
Sodium-dependent noradrenaline transporterSodium-dependent serotonin transporter
AlgoTherapeutix SAS
0 catalysts
Phase 2
amlodipine
Sdamlo (amlodipine [INN])
Anal Fissure
Tavanta Therapeutics Inc
0 catalysts
Phase 2
amsulostat hydrochloride
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Syntara Ltd
0 catalysts
Phase 2
amulirafusp alfa
amulirafusp alfa [INN]
Marginal Zone B-Cell Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
0 catalysts
Phase 2
anpocogin
Antiphospholipid Syndrome
Genvara Biopharma Inc
0 catalysts
Phase 2
antroquinonol
Hocena
Coronavirus Disease 2019 (COVID-19) Pneumonia
Golden Biotechnology Corp
0 catalysts
Phase 2
anvatabart opadotin
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
TubulinReceptor tyrosine-protein kinase erbB-2
Ambrx Biopharma Inc
0 catalysts
Phase 2
anvumetostat
anvumetostat [INN]
Metastatic Biliary Tract Cancer
$AMGNAMGEN INC
0 catalysts
Phase 2
anzutresgene autoleucel
anzutresgene autoleucel [INN]
Endometrial Cancer
Immatics NV
0 catalysts
Phase 2
arcotatug tavatecan
arcotatug tavatecan [INN]
Pancreatic Ductal Adenocarcinoma
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 2
arsenic trioxide 1
Arscimed (arsenic trioxide)
Graft Versus Host Disease (GVHD)
Thioredoxin reductase 1, cytoplasmic
Medsenic SAS
0 catalysts
Phase 2
ascrinvacumab
Metastatic Hepatocellular Carcinoma (HCC)
Activin receptor type-1-like
Kintor Pharmaceutical Ltd
0 catalysts
Phase 2
asengeprast
asengeprast [INN]
Systemic Sclerosis (Scleroderma)
Certa Therapeutics Pty Ltd
0 catalysts
Phase 2
aspacytarabine hydrochloride
Astarabine (aspacytarabine hydrochloride)
Refractory Acute Myeloid Leukemia
Ayala Pharmaceuticals Inc.
0 catalysts
Phase 2
atebimetinib
atebimetinib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
$IMRXImmuneering Corp
0 catalysts
Phase 2
ateganosine
Non-Small Cell Lung Cancer
$MAIAMAIA Biotechnology, Inc.
0 catalysts
Phase 2
atesidorsen sodium
Acromegaly
Percheron Therapeutics Ltd
0 catalysts